|
1
|
Bae S, Kim SY, Jung JH, Yoon Y, Cha HJ,
Lee H, Kim K, Kim J, An IS, Kim J, et al: Akt is negatively
regulated by the MULAN E3 ligase. Cell Res. 22:873–885. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai J, Yang J and Jones DP: Mitochondrial
control of apoptosis: The role of cytochrome c. Biochim Biophys
Acta. 1366:139–149. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jeong SJ, Pise-Masison CA, Radonovich MF,
Park HU and Brady JN: Activated AKT regulates NF-kappaB activation,
p53 inhibition and cell survival in HTLV-1-transformed cells.
Oncogene. 24:6719–6728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang WL, Wang J, Chan CH, Lee SW, Campos
AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG and Lin HK: The
E3 ligase TRAF6 regulates Akt ubiquitination and activation.
Science. 325:1134–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhong L, Cao F and You Q: Effect of TRAF6
on the biological behavior of human lung adenocarcinoma cell. Tumor
Biol. 34:231–239. 2013. View Article : Google Scholar
|
|
6
|
Deng L, Wang C, Spencer E, Yang L, Braun
A, You J, Slaughter C, Pickart C and Chen ZJ: Activation of the
IkappaB kinase complex by TRAF6 requires a dimeric
ubiquitin-conjugating enzyme complex and a unique polyubiquitin
chain. Cell. 103:351–361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng H, Lopez GY, Kim CK, Alvarez A,
Duncan CG, Nishikawa R, Nagane M, Su AJ, Auron PE, Hedberg ML, et
al: EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates
AKT-promoted tumorigenesis. J Clin Invest. 124:3741–3756. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang DH, Qu WL, Shi LQ and Wei J:
Molecular docking and pharmacophore model studies of Rho kinase
inhibitors. Mol Simulat. 37:488–494. 2011. View Article : Google Scholar
|
|
9
|
Pettersen EF, Goddard TD, Huang CC, Couch
GS, Greenblatt DM, Meng EC and Ferrin TE: UCSF chimera-A
visualization system for exploratory research and analysis. J
Comput Chem. 25:1605–1612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hartupee J, Liu C, Novotny M, Sun D, Li X
and Hamilton TA: IL-17 signaling for mRNA stabilization does not
require TNF receptor-associated factor 6. J Immunol. 182:1660–1666.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elumalai P, Arunkumar R, Benson CS,
Sharmila G and Arunakaran J: Nimbolide inhibits IGF-I-mediated
PI3K/Akt and MAPK signalling in human breast cancer cell lines
(MCF-7 and MDA-MB-231). Cell Biochem Funct. 32:476–484.
2014.PubMed/NCBI
|
|
12
|
Schnetzke U, Fischer M, Kuhn AK,
Spies-Weisshart B, Zirm E, Hochhaus A, Müller JP and Scholl S: The
E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in
FLT3-ITD-positive MV4-11 AML cells. J Cancer Res Clin Oncol.
139:605–615. 2013. View Article : Google Scholar
|
|
13
|
Gills JJ and Dennis PA: The development of
phosphatidylinositol ether lipid analogues as inhibitors of the
serine/threonine kinase, Akt. Expert Opin Investig Drugs.
13:787–797. 2004. View Article : Google Scholar
|
|
14
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer Cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishimura M and Naito S: Tissue-specific
mRNA expression profiles of human toll-like receptors and related
genes. Biol Pharm Bull. 28:886–892. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao R, Fan Y, Mou Y, Zhang H, Fu S and
Yang J: TAK1 lysine 158 is required for TGF-β-induced
TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation.
Cell Signal. 23:222–227. 2011. View Article : Google Scholar
|
|
17
|
Chantzoura E, Prinarakis E, Panagopoulos
D, Mosialos G and Spyrou G: Glutaredoxin-1 regulates TRAF6
activation and the IL-1 receptor/TLR4 signalling. Biochem Biophys
Res Commun. 403:335–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Golbano JM, Lóppez-Aparicio P, Recio MN
and Pérez-Albarsanz MA: Finasteride induces apoptosis via Bcl-2,
Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer
cell line. Int J Oncol. 32:919–924. 2008.PubMed/NCBI
|
|
19
|
Alonso-Castro AJ, Ortiz-Sánchez E,
García-Regalado A, Ruiz G, Núñez-Martínez JM, González-Sánchez I,
Quintanar-Jurado V, Morales-Sánchez E, Dominguez F, López-Toledo G,
et al: Kaempferitrin induces apoptosis via intrinsic pathway in
HeLa cells and exerts antitumor effects. J Ethnopharmacol.
145:476–489. 2013. View Article : Google Scholar
|
|
20
|
Xu C, Wu A, Zhu H, Fang H, Xu L, Ye J and
Shen J: Melatonin is involved in the apoptosis and necrosis of
pancreatic cancer cell line SW-1990 via modulating of Bcl-2/Bax
balance. Biomed Pharmacother. 67:133–139. 2013. View Article : Google Scholar
|
|
21
|
Costa LS, Telles CB, Oliveira RM, Nobre
LT, Dantas-Santos N, Camara RB, Costa MS, Almeida-Lima J,
Melo-Silveira RF, Albuquerque IR, et al: Heterofucan from Sargassum
filipendula induces apoptosis in HeLa Cells. Mar Drugs. 9:603–614.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: A
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Xing D and Chen MJ: Bim(L)
displacing Bcl-x(L) promotes bax translocation during TNF
alpha-induced apoptosis. Apoptosis. 13:950–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gardai SJ, Hildeman DA, Frankel SK,
Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL and
Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its
activity and apoptosis in neutrophils. J Biol Chem.
279:21085–21095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Linseman DA, Butts BD, Precht TA, Phelps
RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML and
Heidenreich KA: Glycogen synthase kinase-3 beta phosphorylates bax
and promotes its mitochondrial localization during neuronal
apoptosis. J Neurosci. 24:9993–10002. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zha J, Harada H, Yang E, Jockel J and
Korsmeyer SJ: Serine phosphorylation of death agonist BAD in
response to survival factor results in binding to 14-3-3 not
BCL-XL. Cell. 87:619–628. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marte BM and Downward J: PKB/Akt:
Connecting phosphoinositide 3-kinase to cell survival and beyond.
Trends Biochem Sci. 22:355–358. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scheid MP and Woodgett JR: Unravelling the
activation mechanisms of protein kinase B/Akt. FEBS Lett.
546:108–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
